Skip to main content
Premium Trial:

Request an Annual Quote

Namocell Signs Distribution Deal for Single-Cell Dispenser in Japan

NEW YORK (GenomeWeb) – Namocell announced today that it has signed an agreement with Tomy Digital Biology to distribute Namocell's Namo Single Cell Dispenser in Japan.

Financial details of the agreement were not disclosed.

Namocell's microfluidic-based cell platforms dispense single cells into a 96-well plate in less than a minute, the company said. The firm added that its cell cartridges simplify sterile sorting and eliminate the potential for system clogging.

"The [Japanese] market is in need of a high-performance and cost-effective single-cell dispensing and sorting instrument that is at the same time gentle to the cell and easy to use," Tomy CEO and President Kenjiro Tominaga said in a statement.

In December 2016, Namocell partnered with researchers at Massachusetts General Hospital to research circulating tumor cells using the Namo Single Cell Dispenser platform.